Gilead Sciences, Inc. 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 4:55 pm Purchase | 2021-12-31 | 13G | Sierra Oncology, Inc. SRRA | GILEAD SCIENCES INC. GILD | 1,450,566 9.200% | 377,266 (+35.15%) | Filing |